Vibativ Interactions
There are 333 drugs known to interact with Vibativ (telavancin), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 98 are major, 234 are moderate, and 1 is minor.
- View all 333 medications that may interact with Vibativ
- View Vibativ alcohol/food interactions (1)
- View Vibativ disease interactions (6)
Most frequently checked interactions
View interaction reports for Vibativ (telavancin) and the medicines listed below.
- Achromycin V (tetracycline)
- Actemra (tocilizumab)
- Actos (pioglitazone)
- Adasuve (loxapine)
- Adempas (riociguat)
- Afrezza (insulin inhalation, rapid acting)
- Afrin (oxymetazoline nasal)
- alosetron
- amlodipine
- Ancef (cefazolin)
- AndroGel (testosterone)
- Anucort-HC (hydrocortisone topical)
- Aranesp (darbepoetin alfa)
- Ativan (lorazepam)
- atorvastatin
- Aveed (testosterone)
- Axiron (testosterone)
- azithromycin
- Bactrim (sulfamethoxazole / trimethoprim)
- BD Normal Saline Flush (sodium chloride)
- Blincyto (blinatumomab)
- Bumex (bumetanide)
- buprenorphine
- Bydureon (exenatide)
- caffeine
- Calcium, Magnesium and Zinc (multivitamin with minerals)
- Caprelsa (vandetanib)
- clindamycin
- Lasix (furosemide)
- Plavix (clopidogrel)
Vibativ alcohol/food interactions
There is 1 alcohol/food interaction with Vibativ (telavancin).
Vibativ disease interactions
There are 6 disease interactions with Vibativ (telavancin) which include:
- colitis
- QT prolongation
- coagulation test interference
- hepatic impairment
- nephrotoxicity
- renal impairment
More about Vibativ (telavancin)
- Vibativ consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glycopeptide antibiotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.